196 related articles for article (PubMed ID: 16285312)
1. [Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (PhotoDyn 501): practical experiences in problem-patients with actinic keratoses and basal cell carcinomas].
Kreutzer K; Bonnekoh B; Franke I; Gollnick H
J Dtsch Dermatol Ges; 2004 Dec; 2(12):992-9. PubMed ID: 16285312
[TBL] [Abstract][Full Text] [Related]
2. [Reader's letter concerning K. Kreutzer, B.Bonnekoh, I. Franke, H. Gollnick. Photodynamic therapy with methylaminooxopentanoate (Metvix) and a broad band light source (Photdyn 501): practical experiences in problem patients with actinic keratoses and basal cell carcinomas. JDDG 2004,12:992-999].
Breuninger H
J Dtsch Dermatol Ges; 2005 May; 3(5):397. PubMed ID: 16372809
[No Abstract] [Full Text] [Related]
3. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma.
Caekelbergh K; Annemans L; Lambert J; Roelandts R
Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429
[TBL] [Abstract][Full Text] [Related]
5. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
[TBL] [Abstract][Full Text] [Related]
6. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
7. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
8. Topical methyl aminolevulinate.
Siddiqui MA; Perry CM; Scott LJ
Am J Clin Dermatol; 2004; 5(2):127-37; discussion 138-40. PubMed ID: 15109276
[TBL] [Abstract][Full Text] [Related]
9. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
10. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy.
Fai D; Romano I; Fai C; Cassano N; Vena GA
G Ital Dermatol Venereol; 2016 Apr; 151(2):154-9. PubMed ID: 25279493
[TBL] [Abstract][Full Text] [Related]
11. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P;
Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536
[TBL] [Abstract][Full Text] [Related]
14. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer.
Marmur ES; Schmults CD; Goldberg DJ
Dermatol Surg; 2004 Feb; 30(2 Pt 2):264-71. PubMed ID: 14871220
[TBL] [Abstract][Full Text] [Related]
15. ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy.
Goldman M; Atkin D
J Cosmet Laser Ther; 2003 Jun; 5(2):107-10. PubMed ID: 12850802
[TBL] [Abstract][Full Text] [Related]
16. Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls.
Morton CA
J Dermatolog Treat; 2003; 14 Suppl 3():23-6. PubMed ID: 14522638
[TBL] [Abstract][Full Text] [Related]
17. Current treatments of actinic keratosis.
Gold MH; Nestor MS
J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
[TBL] [Abstract][Full Text] [Related]
18. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.
Lehmann P
Br J Dermatol; 2007 May; 156(5):793-801. PubMed ID: 17419691
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.
Dragieva G; Prinz BM; Hafner J; Dummer R; Burg G; Binswanger U; Kempf W
Br J Dermatol; 2004 Jul; 151(1):196-200. PubMed ID: 15270891
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
